Results 11 to 20 of about 136,043 (299)

Sarcoidosis Illuminations on Living During COVID-19: Patient Experiences of Diagnosis, Management, and Survival Before and During the Pandemic

Journal of Patient Experience, 2022
Background: Inspired by intense challenges encountered by patients and clinicians, we examined the experiences of living with sarcoidosis in three of the hardest impacted English-speaking cities during the early COVID-19 pandemic: London, New Orleans ...
Lesley Ann Saketkoo MD, MPH, Kelly Jensen MD, MPH, Dimitra Nikoletou PhD, MSc, Jacqui J. Newton, Frank J. Rivera BA, Mike Howie, Rodney K. Reese, Melanie Goodman BS, Patricia B. Hart MBA, Whitney Bembry MD, Adam Russell BA, Isabelle Lian MS, Matthew R. Lammi MD, MSCR, Mary Beth Scholand MD, Anne-Marie Russell PhD, APRN, ATSF   +14 more
doaj   +1 more source

Sarcoidosis lung transplantation waitlist mortality, a national registry database study

ERJ Open Research, 2023
Background The Lung Allocation Score (LAS) prioritises lung transplantation candidates, balancing waitlist mortality and post-transplant survival. The score groups sarcoidosis candidates based on mean pulmonary artery pressure: those with ≤30 mmHg ...
Derlis C. Fleitas Sosa, Shameek Gayen, Matthew Zheng, Andrew J. Gangemi, Huaqing Zhao, Victor Kim, Sameep Sehgal, Gerard J. Criner, Rohit Gupta, A. James Mamary   +9 more
doaj   +1 more source

Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study

Respiratory Research, 2022
Background Pirfenidone slows down disease progression in idiopathic pulmonary fibrosis (IPF). Recent studies suggest a treatment effect in progressive pulmonary fibrosis other than IPF.
Jelle R. Miedema, Catharina C. Moor, Marcel Veltkamp, Sara Baart, Natascha S. L. Lie, Jan C. Grutters, Marlies S. Wijsenbeek, Rémy L. M. Mostard   +7 more
doaj   +1 more source

Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study

BMC Pulmonary Medicine, 2020
Background Treatment of pulmonary sarcoidosis is recommended in case of significant symptoms, impaired or deteriorating lung function. Evidence-based treatment recommendations are limited and largely based on expert opinion.
Vivienne Kahlmann, Montse Janssen Bonás, Catharina C. Moor, Coline H. M. van Moorsel, Mirjam Kool, Raisa Kraaijvanger, Jan C. Grutters, Mayka Overgaauw, Marcel Veltkamp, Marlies S. Wijsenbeek, Collaborating investigators   +10 more
doaj   +1 more source

The Relationship between Tumor Development and Sarcoidosis in Aspects of Carcinogenesis before and after the Onset of Sarcoidosis

Medicina, 2022
Background and Objectives: It is still unclear whether sarcoidosis is likely to be associated with tumors. In addition, the use of an immune checkpoint inhibitor has been reported to initiate the onset of sarcoidosis.
Yoshimasa Hachisu, Yasuhiko Koga, Shu Kasama, Kyoichi Kaira, Shogo Uno, Masakiyo Yatomi, Haruka Aoki-Saito, Hiroaki Tsurumaki, Asuka Jingu, Noriaki Sunaga, Toshitaka Maeno, Takeshi Hisada   +11 more
doaj   +1 more source

Nodular Sarcoidosis Masquerading as Cancer. [PDF]

, 2017
Nodular lung disease is a rare pulmonary manifestation of sarcoidosis and resembles metastatic neoplasm disease. Nodular sarcoidosis is rare, varying from 1.6% to 4% of patients with sarcoidosis.
Singh, Navneet K, Stein, Alexander, Sweidan, Alexander J, Tanios, Maged   +3 more
core   +2 more sources

Research progress on drug treament for sarcoidosis [PDF]

Xin yixue, 2023
Sarcoidosis is a systemic disease characterized by non-caseous epithelioid cell granuloma，which can involve with multiple organs，especially the lung. Sarcoidosis is characterized by diverse clinical manifestations and high incidence rate.
Luo Cheng, Wu Cong, Wang Yuguang
doaj   +1 more source

Sarcoidosis-associated hepatocellular carcinoma [PDF]

, 2010
Sarcoidosis is a systemic granulomatous inflammation of unknown etiology, and seems to involve the liver parenchyma in most cases. However, sarcoidosis-associated hepatocellular carcinoma is rare. We report here a case in which a hepatocellular carcinoma
Aiko, Satoshi, Horio, Takuya, Kawai, Toshiaki, Nakanishi, Kuniaki, Ogata, Sho, Saito, Hiroki, Shimazaki, Hideyuki, Sugiura, Yoshiaki   +7 more
core   +1 more source

Characteristics and management of ocular sarcoidosis

Immunological Medicine, 2022
Sarcoidosis is a chronic inflammatory disease of unknown etiology that affects many systemic organs, including the eye. The eye is the second most frequently affected organ in patients with sarcoidosis after lung disease. Approximately 30–50% of patients
Hiroshi Takase
doaj   +1 more source

Association between vitamin d deficiencies in sarcoidosis with disease activity, course of disease and stages of lung involvements [PDF]

, 2017
Background: Despite negative association between 25-hydroxy vitamin D and incidence of many chronic respiratory diseases, this feature was not well studied in sarcoidosis. Current study investigated the association between 25-hydroxy vitamin D deficiency
Abedini, A, Adcock, IM, Kazempour-Dizaji, M, Kiani, A, Mirenayat, MS, Mortaz, E, Taghavi, K   +6 more
core   +1 more source